)

Pila Pharma (PILA) investor relations material
Pila Pharma Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Strategic focus shifted to obesity, alongside type 2 diabetes, driven by industry and investor interest in differentiated metabolic treatments and oral TRPV1 antagonist approaches.
Rights issue and associated financings raised nearly SEK 30 million before costs, oversubscribed by 293.5%, with strong shareholder and management participation.
Engagements with pharmaceutical companies highlighted the need for more data, prompting a focus on proof-of-concept studies in obesity.
Founders and board members increased their stakes, now holding about 15% of shares collectively, with significant set-offs for executive remuneration.
Clinical trial application for PP-CT03 in obesity and diabetes advanced.
Financial highlights
Operating income for H1 2025 was TSEK 851, up from TSEK 683 year-over-year.
EBIT for H1 2025 was TSEK -4,092, nearly unchanged from TSEK -4,082 in H1 2024.
Burn rate remained consistent with the previous half-year period.
Cash position improved significantly post-period due to the oversubscribed rights issue.
Equity at period end was TSEK 1,159, down from TSEK 2,575 year-over-year.
Outlook and guidance
Preclinical in vivo rat studies for obesity are set to begin in autumn, with results expected around New Year or before the TO2 warrant exercise period in February 2026.
Pending positive preclinical results and continued funding, human clinical trials in obesity are planned.
Funds raised are sufficient to finance rat obesity studies and clinical trial application preparations for both diabetes and obesity.
Additional funding possible from warrant exercise, potentially up to SEK 90 million.
The company is well-funded for upcoming studies, with prudent spending expected.
Next Pila Pharma earnings date

Next Pila Pharma earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage